Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The use of NNMT inhibitors as a potential obesity treatment has been investigated preclinically 8,9,13 , and observational clinical data suggests that increased NNMT expression and activity correlate with increased incidence of Type 2 diabetes (T2D) and risk of obesity, respectively 10,11
Certificate of Analysis Each batch is tested by an independent third-party laboratory for: Peptide identity verification Purity analysis via HPLC (99%) Microbial contaminant screening Heavy metal analysis Residual solvent testing Description FOXO4-DRI is a D-retro-inverso peptide designed to interfere with the FOXO4-p53 interaction, supplied as a lyophilized 10mg vial
Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles
High Potassium content also helps balance the Potassium to Sodium ratio in the body
01185-6/asset/4a8b6ac7-0944-49bb-a528-111e459b6c4e/main.assets/gr1.jpg)
:max_bytes(150000):strip_icc()/VWH_NEWS_GLP1_TastePerception-579dc0e01a604949af26d0e23e75b7fc.png)
